HitGen LTD-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014272
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company offers OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It provides biological reagents, edge technology and services for progression of projects and services. HitGen’s services include lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, and others. It serves contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HitGen Enters into Agreement with Takeda Pharma 10
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 11
HitGen Enters into Agreement with Aduro Biotech 12
HitGen Enters into Research Agreement with LEO Pharma 13
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 14
HitGen Enters into Agreement with Merck 15
HitGen Enters into Agreement with Janssen Biotech 16
HitGen Enters into Research Agreement with Global Blood Therapeutics 17
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 18
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 19
Licensing Agreements 20
Pfizer Enters into Licensing Agreement with HitGen 20
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 21
HitGen LTD – Key Competitors 22
HitGen LTD – Key Employees 23
HitGen LTD – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HitGen LTD, Deals By Therapy Area, 2011 to YTD 2017 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
HitGen Enters into Agreement with Takeda Pharma 10
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 11
HitGen Enters into Agreement with Aduro Biotech 12
HitGen Enters into Research Agreement with LEO Pharma 13
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 14
HitGen Enters into Agreement with Merck 15
HitGen Enters into Agreement with Janssen Biotech 16
HitGen Enters into Research Agreement with Global Blood Therapeutics 17
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 18
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 19
Pfizer Enters into Licensing Agreement with HitGen 20
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 21
HitGen LTD, Key Competitors 22
HitGen LTD, Key Employees 23
HitGen LTD, Subsidiaries 24

★海外企業調査レポート[HitGen LTD-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Radiation Monitoring Devices Inc:製品パイプライン分析
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipli …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Versalis SpA:企業の戦略的SWOT分析
    Versalis SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Seplat Petroleum Development Company Plc (SEPLAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Seplat Petroleum Development Company Plc (Seplat) is an independent upstream exploration and production company that offers development and operation of oil and natural gas reserves and production assets. The company produces oil from fileds such as Amukpe, Oben, Okporhuru, Ovhor, Orogho, Sa …
  • Krispy Kreme Doughnuts, Inc.:企業の戦略的SWOT分析
    Krispy Kreme Doughnuts, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly known as Isotechnika Pharma Inc, develops and commercialization of therapies. The company pipeline product Voclosporin, is used for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS); and voclos …
  • Corvel Corporation:企業の戦略・SWOT・財務分析
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Universal Health Services, Inc.:企業の戦略・SWOT・財務情報
    Universal Health Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Universal Health Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Qiagen Marseille SA-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen Marseille SA (HalioDx), formerly Ipsogen SA is a subsidiary of Qiagen NV, a drugs manufacturing company that develops and markets molecular diagnostic tests. The company offers products for the treatment of chronic myeloid, chronic lymphocytic, acute myeloid, and acute lymphoblastic l …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal a …
  • Korea National Oil Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Korea National Oil Corporation (KNOC) is a state-owned integrated energy company that carries out the exploration, development and production of oil and gas, and stockpiling of petroleum resources. The company purchases and sells crude oil, distribute gasoline and gasoline oil and sells refi …
  • Becton Dickinson and Co (BDX)-医療機器分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery, an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆